8URG | pdb_00008urg

Human mitochondrial calcium uniporter crystal structure (residues 74-165 resolved) with lithium


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.63 Å
  • R-Value Free: 
    0.227 (Depositor), 0.221 (DCC) 
  • R-Value Work: 
    0.199 (Depositor), 0.195 (DCC) 
  • R-Value Observed: 
    0.200 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

Disrupting the network of co-evolving amino terminal domain residues relieves mitochondrial calcium uptake inhibition by MCUb.

Colussi, D.M.Grainger, R.Noble, M.Lake, T.Junop, M.Stathopulos, P.B.

(2025) Comput Struct Biotechnol J 27: 190-213

  • DOI: https://doi.org/10.1016/j.csbj.2024.12.007
  • Primary Citation of Related Structures:  
    8URG

  • PubMed Abstract: 

    The regulatory mechanisms of the mitochondrial calcium uniporter complex (mtCU), the predominant channel mediating calcium (Ca 2 + ) flux into the matrix, are critical for bioenergetics and cell fate. The pore-forming components of mtCU are the mitochondrial Ca 2+ uniporter (MCU) subunit and the MCU dominant-negative beta (MCUb) subunit. Despite both MCU paralogs having conserved Asp-Ile-Met-Glu motifs responsible for Ca 2+ selectivity, MCUb mediates only low Ca 2+ conduction and has been characterized as an inhibitory subunit. We previously identified the MCU amino-terminal domain (NTD) as a negative feedback regulator of mtCU upon divalent cation binding but the role of the MCUb-NTD remains unknown. Thus, to gain mechanistic insight into the competing MCU and MCUb functions, we here studied the divalent cation binding properties of the MCU- and MCUb-NTDs that tightly interact within and between tetrameric channels. First, we resolved a high-resolution MCU-NTD crystal structure in the absence of divalent ions at 1.6 Å, using this structure to model the homologous MCUb-NTD. Further, we conducted 1 μs all-atom molecular dynamics (MD) simulations in the presence and absence of Ca 2+ and Mg 2+ ions, not only finding increased MCU-NTD stability at high temperatures compared to MCUb-NTD but also discrete Ca 2+ -binding sites on the two domains. Remarkably, the distinct Ca 2+ binding site on the central α-helix of MCUb-NTD was also identified in a functional sector of co-evolving residues, with either direct mutation to the coordinating residues or mutation to a separate site within the sector disrupting Ca 2+ binding in silico and in vitro as well as enhancing mitochondrial Ca 2+ uptake in cellulo . Thus, we reveal that matrix Ca 2+ binding to both the MCU-NTD and MCUb-NTD promote mtCU inhibition through disparate interaction sites, highlighting the evolution of discrete feedback regulation mechanisms to precisely control mtCU function.


  • Organizational Affiliation
    • Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, N6A5C1, Canada.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Calcium uniporter protein, mitochondrial124Homo sapiensMutation(s): 0 
Gene Names: MCUC10orf42CCDC109A
UniProt & NIH Common Fund Data Resources
Find proteins for Q8NE86 (Homo sapiens)
Explore Q8NE86 
Go to UniProtKB:  Q8NE86
PHAROS:  Q8NE86
GTEx:  ENSG00000156026 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ8NE86
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.63 Å
  • R-Value Free:  0.227 (Depositor), 0.221 (DCC) 
  • R-Value Work:  0.199 (Depositor), 0.195 (DCC) 
  • R-Value Observed: 0.200 (Depositor) 
Space Group: P 65
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 55.52α = 90
b = 55.52β = 90
c = 69.11γ = 120
Software Package:
Software NamePurpose
PHENIXrefinement

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Canadian Institutes of Health Research (CIHR)Canada438225

Revision History  (Full details and data files)

  • Version 1.0: 2025-01-22
    Type: Initial release
  • Version 1.1: 2025-03-12
    Changes: Database references